Using ecological criteria to design plant collection strategies for drug discovery

Frontiers in Ecology and the Environment

Volumn 1, Issue 8, 2003, Pages 421-428

  Coley, Phyllis D ^a,b   Heller, Maria V ^b   Aizprua, Rafael ^b   Araúz, Blanca ^b   Flores, Nayda ^b   Correa, Mireya ^b,c   Gupta, Mahabir ^c   Solis, Pablo N ^c   Ortega Barría, Eduardo ^d   Romero, Luz I ^d   Gómez, Basilio ^c   Ramos, Marla ^c   Cubilla Rios, Luis ^c   Capson, Todd L ^b   Kursar, Thomas A ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b SMITHSONIAN TROPICAL RESEARCH INSTITUTE   (Panama)

^c UNIVERSIDAD DE PANAMÁ   (Panama)

^d Institute of Advanced Scientific Investigations and High Technology   (Panama)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 3042648840     PISSN: 15409295     EISSN: 15409309     Source Type: Journal    
DOI: 10.1890/1540-9295(2003)001[0421:UECTDP]2.0.CO;2     Document Type: Review

References (61)

1. Agnew B. 2000. When pharma merges, R&D is the dowry. Science 287: 1952-53.
2. Balick MJ, Elisabetsky E, and Laird SA (Eds). 1996. Medicinal resources of the tropical forest: biodiversity and its importance to human health. New York: Columbia University Press.
3. Balmford A, Bruner A, Cooper P, et al. 2002. Economic reasons for conserving wild nature. Science 297: 950-53.
4. Balvanera P, Daily GC, Ehrlich PR, et al. 2001. Conserving biodiversity and ecosystem services. Science 291: 2047.
5. Barclay AS and Perdue RE, Jr. 1976. Distribution of anticancer activity in higher plants. Cancer Treat Rep 60: 1081-113.
6. Beattie AJ and Ehrlich PR. 2001. Wild solutions: how biodiversity is money in the bank. New Haven, CT: Yale University Press.
7. Bennett BC. 1992. Uses of epiphytes, lianas and parasites by Shuar people of Amazonian Ecuador. Selbyana 13: 99-114.
8. Bonetto G, Hussein AA, Barberena I, et al. 2003. Ecologically based bioprospecting in Panama. Part 3: A cytotoxic diterpene from Prioria copaifera (Fabaceae). Fitoterapia. In press.
9. Capson TL, Coley PD, and Kursar TA. 1996. A new paradigm for drug discovery in tropical rainforests. Nat Biotechnol 14: 1200-02.
10. Chérigo L, Polanco V, Ortega-Barría E, et al. 2003. Anti-trypanosomal activity of a novel norlignan purified from Nectandra lineata. Nat Prod Res. In press.
11. Coley PD. 1983. Herbivory and defense characteristics of tree species in a lowland tropical forest. Ecol Monogr 53: 209-33.
12. Coley PD. 1988. Effects of plant growth rate and leaf lifetime on the amount and type of anti-herbivore defense. Oecologia 74: 531-6.
13. Coley PD and Aide TM. 1991. Comparison of herbivory and plant defenses in temperate and tropical broad-leaved forests. In: PW Price, TM Lewinsohn, WW Fernandes, and WW Benson (Eds). Plant-animal interactions: evolutionary ecology in tropical and temperate regions. New York: John Wiley & Sons. p 25-49.
14. Coley PD and Barone JA. 1996. Herbivory and plant defenses in tropical forests. Ann Rev Ecol Syst 27: 305-35.
15. Coley PD, Bryant J P, and Chapin FS III. 1985. Resource availability and plant anti-herbivore defense. Science 230: 895-99.
16. Coley PD and Kursar TA. 1996. Anti-herbivore defenses of young tropical leaves: physiological constraints and ecological tradeoffs. In: Mulkey SS, Chazdon R, and Smith AP (Eds). Tropical forest plant ecophysiology. New York: Chapman and Hall. p 305-36.
17. Cork SJ. 2002. Ecosystem services and costing. In: Mooney HA and Canadell J (Eds). The Earth system: biological and ecological dimensions of global environmental change. Encyclopedia of global environment change. New York: John Wiley & Sons. p 272-81.
18. Cox PA. 2001. Ensuring equitable benefits: the Falealupo covenant and the isolation of anti-viral drug prostratin from a Samoan medicinal plant. Pharm Biol 39 (suppl): 33-40.
19. Cragg GM and Newman DJ. 1999. Discovery and development of antineoplastic agents from natural sources. Cancer Invest 17: 153-63.
20. Crankshaw DR and Langenheim JH. 1981. Variation in terpenes and phenolics through leaf development in Hymenaea and its possible significance to herbivory. Biochem Syst Ecol 9: 115-24.
21. Daily GC and Ellison K. 2002. The new economy of nature: the quest to make conservation profitable. Washington DC: Island Press/Shearwater Books.
22. Daily GC, Soderqvist T, Aniyar S, et al. 2000. The value of nature and the nature of value. Science 289: 395-96.
23. Ehrlich PR and Raven PH. 1964. Butterflies and plants: a study in coevolution. Evolution 18: 586-608.
24. Gentry AH. 1993. Tropical forest biodiversity and the potential for new medicinal plants. In: Kinghorn AD and Balandrin MF (Eds). Human medicinal agents from plants. American Chemical Society Symposium Ser 534. Washington DC: American Chemical Society. p 13-24.
25. Grifo F and Rosenthal J (Eds). 1997. Biodiversity and human health. Washington DC: Island Press.
26. Grime J P. 1979. Plant strategies and vegetative processes. New York: John Wiley and Sons.
27. Hegarty MP, Hegarty EE, and Gentry AH. 1991. Secondary compounds in vines with an emphasis on those with defensive functions. In: Putz FE and Mooney HA (Eds). The biology of vines. Cambridge, UK: Cambridge University Press. p 287-310.
28. Hussein A, Bozzi B, Correa M, et al. 2003. Ecologically based bio-prospecting in Panama. Part 1: bioactive constituents from three Vismia species. J Nat Prod 66: 858-60.
29. Janzen D. 1999. Gardenification of tropical conserved wildlands: multitasking, multicropping, and multiusers. Proc Natl Acad Sci USA 96: 5987-94.
30. Janzen DH. 1997. How to grow a wildland: the gardenification of nature. Insect Sci Appl 17: 269-76.
31. Kareiva P. 1999. Coevolutionary arms races: is victory possible? Proc Natl Acad Sci USA 96: 8-10.
32. Kinghorn AD and Balandrin MF (Eds). 1993. Human medicinal agents from plants. ACS Symposium Series No. 534, American Chemical Society, Washington DC.
33. Kingston DGI, Abdel-Kader M, Zhou B-N, et al. 1999. The Suriname International Cooperative Biodiversity Group program: lessons from the first five years. Pharm Biol 37 (suppl): 22-34.
34. Kursar TA, Capson TL, Coley PD, et al. 1999. Ecologically guided bioprospecting in Panama. Pharm Biol 37 (suppl): 114-26.
35. Kursar TA and Coley PD. 2003. Convergence in defense syndromes of young leaves in tropical rainforests. Biochem Syst Ecol. 31: 929-49
36. Langenheim JH, Macedo CA, Ross MK, and Stubblebine WH. 1986. Leaf development in the tropical leguminous tree Copaifera in relation to microlepidopteran herbivory. Biochem Syst Ecol 14: 51-59.
37. Levin DA. 1976. Alkaloid-bearing plants: an ecogeographic perspective. Am Nat 110: 261-84.
38. Levin DA and York BM. 1978. The toxicity of plant alkaloids: an ecogeographic perspective. Biochem Syst Ecol 6: 61-76.
39. Lewis WH, Lamas G, Vaisberg A, et al. 1999. Peruvian medicinal plant sources of new pharmaceuticals (International Cooperative Biodiversity Group - Peru). Pharm Biol 37 (suppl): 69-83.
40. Love J. 1999. Who pays what in drug development. Nature 397: 202.
41. Lowman MD and Box JD. 1983. Variation in leaf toughness and phenolic content among five species of Australian rain forest trees. Aust J Ecol 8: 17-25.
42. Lucas PW, Turner IM, Dominy NJ, and Yamashita N. 2000. Mechanical defences to herbivory. Ann Bot 86: 913-20.
43. Mann J. 2002. Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer 2: 143-48.
44. Marquis RJ and Braker HE. 1993. Plant-herbivore interactions: diversity, specificity and impact. In: McDade LA, Bawa KS, Hespenheide HA and Hartshorn GS (Eds). La Selva: ecology and natural history of a neotropical rain forest. Chicago: University of Chicago Press. p 261-81.
45. Mendoza DT, Ureña González LD, Ortega-Barría E, et al. 2003. Five new cassane diterpenes from Myrospermum frutescens with activity against Trypanosoma cruzi. J Nat Prod 66: 928-32.
46. Montenegro H, Guttiuérrez M, Romero LI, et al. 2003. Aporphine alkaloids from Guatteria spp. with leishmanicidal activity. Planta Med 69: 677-88.
47. Pimm SL. 2001. The world according to Pimm: a scientist audits the Earth. New York: McGraw Hill.
48. Price PW, Lewinsohn TM, Fernandes GW, and Benson WW (Eds). 1991. Plant-animal interactions. New York: John Wiley and Sons.
49. Rausher MD. 2001. Co-evolution and plant resistance to natural enemies. Nature 411: 857-64.
50. Reich PB, Ellsworth DS, Walters MB, et al. 1999. Generality of leaf trait relationships: a test across six biomes. Ecology 80: 1955-69.
51. Reid W V, Laird SA, Meyer CA, et al. (Eds) 1993. Biodiversity prospecting: using genetic resources for sustainable development. Washington DC: World Resources Institute.
52. Rosenthal J P, Beck D, Bhat A, et al. 1999. Combining high risk science with ambitious social and economic goals. Pharm Biol 37 (suppl): 6-21.
53. Rosenzweig ML. 2003. Win-win ecology: how the Earth's species can survive in the midst of human enterprise. New York: Oxford University Press.
54. Sala OE, Chapin FS III, Armesto JJ, et al. 2000. Global biodiversity scenarios for the year 2100. Science 287: 1770-74.
55. Schuster BG, Jackson JE, Obijiofor CN, et al. 1999. Drug development and conservation of biodiversity in West and Central Africa: a model for collaboration with indigenous people. Pharm Biol 37 (suppl): 84-99.
56. Shu YZ. 1998. Recent natural products-based drug development: a pharmaceutical industry perspective. J Nat Prod 61: 1053-71.
57. ten Kate K and Laird SA. 1999. The commercial use of biodiversity: access to genetic resources and benefit-sharing. London: Earthscan Publications.
58. Thompson JN. 1999. The evolution of species interactions. Science 284: 2116-18.
59. Tilman D, Fargione J, Wolff B, et al. 2001. Forecasting agriculturally driven global environmental change. Science 292: 281-84.
60. Vitousek PM, Mooney HA, Lubchenco J, and Mellilo JM. 1997. Human domination of Earth's ecosystems. Science 277: 494-99.
61. Wright IJ, Westoby M, and Reich PB. 2002. Convergence towards higher leaf mass per area in dry and nutrient-poor habitats has different consequences for leaf life span. J Ecol 90: 534-43.